Type III hypersensitivity reactions to a B cell epitope antigen are abrogated using a depot forming vaccine platform

Type III hypersensitivity reactions to a B cell epitope antigen are abrogated using a depot forming vaccine platform

Peptide antigens are combined with an adjuvant in order to increase immunogenicity in vivo. The immunogenicity and safety of a RSV vaccine formulated in a novel oil-based platform, DepoVax™ (DPX), was compared to an alum formulation. A peptide B cell epitope derived from RSV small hydrophobic ectodo...

Full description

Saved in:
Bibliographic Details
Main Authors: Lisa D. MacDonald (Author), Alecia MacKay (Author), Valarmathy Kaliaperumal (Author), Genevieve Weir (Author), Andrea Penwell (Author), Rajkannan Rajagopalan (Author), Joanne M. Langley (Author), Scott Halperin (Author), Marc Mansour (Author), Marianne M. Stanford (Author)
Format: Book
Published: Taylor & Francis Group, 2018-01-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items